Business Context and Reporting Period
This Form 8-K is filed by PharmAthene, Inc. (not Altimmune, Inc.) on March 11, 2014. The report announces the financial and operating results for the fiscal year ended December 31, 2013. The company is incorporated in Delaware and maintains its principal executive offices in Annapolis, Maryland.
Key Financial Metrics
The filing text serves as a notification of results and does not contain specific numerical data. The following metrics are not provided in this document: revenue, profit, cash flow, margins, debt, or liquidity figures. These details are referenced as being contained in the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing does not provide specific data to compare against prior periods. It only states that results for the year ended December 31, 2013, have been announced. No material changes in financial condition or operations are quantified in this text.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, or specific risk factors. It includes a standard disclaimer stating that the information in this Current Report, including the referenced press release, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for PharmAthene, Inc., not Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated March 11, 2014) to obtain actual financial figures for the year ended December 31, 2013.
- Confirm the company's current status, as this filing is from 2014 and the company may have undergone name changes, mergers, or delistings since then.